Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the inclusion in this Registration Statement on Form S-1 and the related prospectus of our report dated March 29, 2024, of our audit of the consolidated financial statements of Processa Pharmaceuticals, Inc. as of and for the years ended December 31, 2023 and 2022. We also consent to the reference to our firm under the caption “Experts” in such Registration Statement.
| /s/ BD & Company, Inc. | |
| Owings Mills, MD | |
| December 20, 2024 |
